Taipei, Taiwan

Ching-Hsuan Hsu

USPTO Granted Patents = 6 

 

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Taipei, TW (2022)
  • Taoyuan, TW (2023)
  • Taoyaun, TW (2023)

Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations of Ching-Hsuan Hsu in Cancer Treatment

Introduction

Ching-Hsuan Hsu is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of cancer treatment through his innovative patents. With a total of 6 patents, Hsu's work focuses on developing novel therapeutic approaches that enhance T-cell activation and regulate cancer.

Latest Patents

One of Hsu's latest patents is titled "Bispecific CD137-binding antibodies for T-cell activation." This patent describes antibodies that include an antigen binding region that binds to CD137. Additionally, it provides bispecific antibodies that feature a first antigen binding region that binds to CD137 and a second region that binds to an immune checkpoint molecule, an immune stimulatory molecule, or a tumor antigen. The patent also includes pharmaceutical compositions that utilize these antibodies and methods for treating cancer.

Another significant patent is "PD-L1 and OX40 binding proteins for cancer regulation." This patent presents monospecific and bispecific proteins that specifically bind to OX40 and/or PD-L1. The exemplary proteins are designed to release inhibition through PD-L1 and stimulate T cells through OX40. Furthermore, the patent describes polyvalent proteins that comprise at least one OX40 binding site and at least one PD-L1 binding site, with potential linking through an immunoglobulin constant region.

Career Highlights

Ching-Hsuan Hsu has worked with notable companies in the biotechnology sector, including Ap Biosciences Inc. and Allgenesis Biotherapeutics Inc. His experience in these organizations has contributed to his expertise in developing innovative cancer therapies.

Collaborations

Hsu has collaborated with several professionals in his field, including Jeng-Horng Her and Jhong-Jhe You. These collaborations have likely enhanced the development and application of his innovative ideas.

Conclusion

Ching-Hsuan Hsu's contributions to cancer treatment through his innovative patents demonstrate his commitment to advancing medical science. His work continues to inspire new approaches in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…